CAS No. |
2307488-83-9 |
|---|---|
英文名称 |
- |
别名 |
Tarlatamab;Research Grade Tarlatamab (DHK06402);Research Grade Tarlatamab |
用途 |
Tarlatamab is a first-in-class HLE BiTE (bispecific T-cell engager) immunotherapy targeting DLL3, with potential for research in small cell lung cancer (SCLC). |
|
|
评论 |
|---|